Abiomed, Inc. ABMD
Set alert
381.02 +381.02 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 17.18B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 60.77
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 2, 2023
- 50-d avg
- 351.42
- 200-d avg
- 291.67
- 1y target
- 0.00
Analyst view
Consensus: hold
Hold
Price target (mean) 0.00
Ratings (0m) 10 8 buy · 2 hold · 0 sell
- Strong buy5
- Buy3
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 10
- 2 months ago 10
- 3 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 1.13 | 0.0% | 295.37M | +13.1% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 1.16 | 0.0% | 308.25M | +14.2% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 1.14B | +10.8% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 1.36B | +18.7% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 1, 2022 | Morgan Stanley | Upgrade | Underweight | Equal-Weight |
| Nov 1, 2022 | Deutsche Bank | Downgrade | Buy | Hold |
| Oct 31, 2022 | William Blair | Downgrade | Outperform | Market Perform |
| Oct 31, 2022 | Piper Sandler | Downgrade | Overweight | Neutral |
| Oct 12, 2022 | Mizuho | Initiated | — | Buy |
| Oct 9, 2022 | Piper Sandler | Maintained | — | Overweight |
| Jul 20, 2022 | Deutsche Bank | Maintained | — | Buy |
| Jul 14, 2022 | Morgan Stanley | Maintained | — | Underweight |
| Apr 5, 2022 | Wolfe Research | Initiated | — | Peer Perform |
| Feb 3, 2022 | Morgan Stanley | Maintained | — | Underweight |
| Feb 3, 2022 | SVB Leerink | Maintained | — | Market Perform |
| Jan 6, 2022 | Morgan Stanley | Maintained | — | Underweight |
| Aug 5, 2021 | SVB Leerink | Maintained | — | Market Perform |
| Jul 19, 2021 | SVB Leerink | Maintained | — | Market Perform |
| Jun 17, 2021 | Deutsche Bank | Initiated | — | Buy |
| Jan 28, 2021 | Morgan Stanley | Maintained | — | Underweight |
| Jan 28, 2021 | SVB Leerink | Maintained | — | Market Perform |
| Dec 14, 2020 | Morgan Stanley | Maintained | — | Underweight |
| Oct 11, 2020 | SVB Leerink | Maintained | — | Market Perform |
| Aug 6, 2020 | Morgan Stanley | Maintained | — | Underweight |
| Aug 6, 2020 | SVB Leerink | Maintained | — | Market Perform |
| May 27, 2020 | SVB Leerink | Reiterated | — | Market Perform |
| Apr 30, 2020 | Morgan Stanley | Maintained | — | Underweight |
| Apr 30, 2020 | SVB Leerink | Maintained | — | Market Perform |
| Apr 26, 2020 | SVB Leerink | Downgrade | Outperform | Market Perform |
| Mar 26, 2020 | Morgan Stanley | Maintained | — | Underweight |
| Mar 22, 2020 | Stephens & Co. | Maintained | — | Overweight |
| Feb 11, 2020 | Morgan Stanley | Downgrade | Equal-Weight | Underweight |
| Dec 16, 2019 | Morgan Stanley | Maintained | — | Equal-Weight |
| Oct 28, 2019 | Raymond James | Downgrade | Outperform | Market Perform |